Novanta NOVT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Novanta (NOVT) Business Model and Operations Summary
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Key Insights
Novanta (NOVT) Core Market Data and Business Metrics
Latest Closing Price
$127.5Market Cap
$4.58 BillionPrice-Earnings Ratio
72.03Total Outstanding Shares
35.96 Million SharesTotal Employees
3,000Dividend
No dividendIPO Date
March 24, 1999SIC Description
Miscellaneous Electrical Machinery, Equipment & SuppliesPrimary Exchange
NASDAQHeadquarters
125 Middlesex Turnpike, Bedford, MA, 01730
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $158.51 Million |
| Net Cash Flow From Investing Activities | $-208.19 Million |
| Net Cash Flow | $7.27 Million |
| Net Cash Flow, Continuing | $7.27 Million |
| Net Cash Flow From Financing Activities, Continuing | $56.94 Million |
| Net Cash Flow From Investing Activities, Continuing | $-208.19 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss | $64.09 Million |
| Operating Expenses | $310.96 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Diluted Average Shares | $36.12 Million |
| Diluted Earnings Per Share | $1.77 |
| Depreciation and Amortization | $55.56 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $58.20 Million |
| Comprehensive Income/Loss Attributable To Parent | $58.20 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-5.88 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Liabilities | $475.02 Million |
| Intangible Assets | $185.84 Million |
| Inventory | $144.61 Million |
| Other Non-current Assets | $655.88 Million |
| Current Liabilities | $167.79 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||